Make implants more accessible through gentle and efficient removals
RemovAid
RemovAid is an ISO 13485:2016 certified company who specializes in the development, manufacture and distribution of medical devices which remove subdermal implants.
Based on its proprietary and patented technology the company has developed a class IIa medical device to remove single-rod contraceptives. The product is CE approved under MDR 2017/745 and distributed for sale in Norway as the pilot country.
Lifecare acquired 89.6% of the shares in RemovAid in 2024.
With the acquisition of 89.6% of RemovAid in 2024, Lifecare has secured a unique user-friendly medical device for removal of subdermal implants. The Sencell sensor will be injected under the skin, and with some manufacturing adjustments, RemovAid is envisioned applicable for the removal of the Sencell sensor from humans and pets. The acquisition has also enabled access to a new market for Lifecare, as RemovAid is already sold to a number of health clinics in Norway as a user-friendly tool for removing contraceptives. Lifecare intends to continue to manufacture and distribute the tool to the contraceptive market both in Norway and abroad, with a specific focus on Sub-Saharan Africa, which represents a large market for this type of contraceptives.
Learn more: www.removaid.com